BIOT
Biotech Acquisition Company Class A Ordinary Shares
BIOT
BIOT
Delisted
BIOT was delisted on the 2nd of February, 2023.
76 hedge funds and large institutions have $218M invested in Biotech Acquisition Company Class A Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
76
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.93M | |
| 2 | +$4.61M | |
| 3 | +$1.99M | |
| 4 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
+$1.88M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.77M |
Top Sellers
| 1 | -$4.92M | |
| 2 | -$2.95M | |
| 3 | -$1.17M | |
| 4 |
GCL
Glazer Capital LLC
New York
|
-$1.09M |
| 5 |
RA
Ramius Advisors
New York
|
-$984K |